000 01003 a2200301 4500
005 20250513000110.0
264 0 _c19810413
008 198104s 0 0 eng d
022 _a0361-5960
040 _aNLM
_beng
_cNLM
100 1 _aWarrell, R P
245 0 0 _aPhase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
_h[electronic resource]
260 _bCancer treatment reports
_c
300 _a1157-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAminoacridines
_xadverse effects
650 0 4 _aAmsacrine
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aDrug Evaluation
650 0 4 _aHumans
650 0 4 _aLymphoma
_xdrug therapy
650 0 4 _aMiddle Aged
700 1 _aStraus, D J
700 1 _aYoung, C W
773 0 _tCancer treatment reports
_gvol. 64
_gno. 10-11
_gp. 1157-8
999 _c6893680
_d6893680